Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin

Nature

Volumn 456, Issue 7220, 2008, Pages 409-412

  Hanna, Rachel A ^a   Campbell, Robert L ^a   Davies, Peter L ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALPAIN 2; CALPASTATIN; CYSTEINE; HETERODIMER;

AMINO ACID; APOPTOSIS; CALCIUM; CRYSTAL STRUCTURE; ENZYME ACTIVITY; GENE EXPRESSION; INHIBITION; INHIBITOR; PROTEIN;

ARTICLE; CALCIUM BINDING; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME STRUCTURE; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

MAMMALIA;

EID: 56749172400     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature07451     Document Type: Article

References (33)

1. Goll, D. E., Thompson, V. F., Li, H., Wei, W. & Cong, J. The calpain system. Physiol. Rev. 83, 731-801 (2003).
2. Glading, A., Lauffenburger, D. A. & Wells, A. Cutting to the chase: Calpain proteases in cell motility. Trends Cell Biol. 12, 46-54 (2002).
3. Franco, S. J. & Huttenlocher, A. Regulating cell migration: Calpains make the cut. J. Cell Sci. 118, 3829-3838 (2005).
4. Abe, K. & Takeichi, M. NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression. Neuron 53, 387-397 (2007).
5. Wendt, A., Thompson, V. F. & Goll, D. E. Interaction of calpastatin with calpain: A review. Biol. Chem. 385, 465-472 (2004).
6. Hanna, R. A., Garcia-Diaz, B. E. & Davies, P. L. Calpastatin simultaneously binds four calpains with different kinetic constants. FEBS Lett. 581, 2894-2898 (2007).
7. Betts, R., Weinsheimer, S., Blouse, G. E. & Anagli, J. Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT. J. Biol. Chem. 278, 7800-7809 (2003).
8. Todd, B. et al. A structural model for the inhibition of calpain by calpastatin: Crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. J. Mol. Biol. 328, 131-146 (2003).
9. Pfizer, J., Assfalg-Machleidt, I., Machleidt, W. & Schaschke, N. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides. Biol. Chem. 389, 83-90 (2008).
10. Moldoveanu, T., Gehring, K. & Green, D. R. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature doi:10.1038/nature07353 (this issue).
11. 2+ exchanger in excitotoxicity. Cell 120, 275-285 (2005).
12. Maekawa, A. et al. Overexpression of calpastatin by gene transfer prevents troponin I degradation and ameliorates contractile dysfunction in rat hearts subjected to ischemia/reperfusion. J. Mol. Cell. Cardiol. 35, 1277-1284 (2003).
13. Neffe, A. T. & Abell, A. D. Developments in the design and synthesis of calpain inhibitors. Curr. Opin. Drug Discov. Dev. 8, 684-700 (2005).
14. Hosfield, C. M., Elce, J. S., Davies, P. L. & Jia, Z. Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation. EMBO J. 18, 6880-6889 (1999).
15. Strobl, S. et al. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc. Natl Acad. Sci. USA 97, 588-592 (2000).
16. Takano, E., Ma, H., Yang, H. Q., Maki, M. & Hatanaka, M. Preference of calcium-dependent interactions between calmodulin-like domains of calpain and calpastatin subdomains. FEBS Lett. 362, 93-97 (1995).
17. Moldoveanu, T. et al. A Ca(2+) switch aligns the active site of calpain. Cell 108, 649-660 (2002).
18. Croall, D. E. & McGrody, K. S. Domain structure of calpain: Mapping the binding site for calpastatin. Biochemistry 33, 13223-13230 (1994).
19. Elce, J. S., Hegadorn, C., Gauthier, S., Vince, J. W. & Davies, P. L. Recombinant calpain II: Improved expression systems and production of a C105A active-site mutant for crystallography. Protein Eng. 8, 843-848 (1995).
20. Maki, M. et al. Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J. Biol. Chem. 264, 18866-18869 (1989).
21. Cuerrier, D., Moldoveanu, T. & Davies, P. L. Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: The importance of primed side interactions. J. Biol. Chem. 280, 40632-40641 (2005).
22. Ishima, R. et al. Structure of the active 27-residue fragment of human calpastatin. FEBS Lett. 294, 64-66 (1991).
23. Otlewski, J., Filip, J., Zakrzewska, M. & Oleksy, A. The many faces of protease-protein inhibitor interaction. EMBO J. 24, 1304-1310 (2005).
24. Li, M. et al. The aspartic proteinase from Saccharomyces cerevisiae folds its own inhibitor into a helix. Nature Struct. Biol. 7, 113-117 (2000).
25. Hurley, T. D. et al. Structural basis for regulation of protein phosphatase 1 by inhibitor-2. J. Biol. Chem. 282, 28874-28883 (2007).
26. 2+-regulated phospholipid-binding domain. Biochem. Biophys. Res. Commun. 280, 1333-1339 (2001).
27. 2+ binding at two non-EF-hand sites. J. Biol. Chem. 279, 6106-6114 (2004).
28. Moldoveanu, T., Campbell, R. L., Cuerrier, D. & Davies, P. L. Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site. J. Mol. Biol. 343, 1313-1326 (2004).
29. Minor, W., Cymborowski, M., Otwinowski, Z. & Chruszcz, M. HKL-3000: The integration of data reduction and structure solution - from diffraction images to an initial model in minutes. Acta Crystallogr. D 62, 859-866 (2006).
30. Collaborative Computational Project Number 4. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
31. Read, R. J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. D 57, 1373-1382 (2001).
32. Storoni, L. C., McCoy, A. J. & Read, R. J. Likelihood-enhanced fast rotation functions. Acta Crystallogr. D 60, 432-438 (2004).
33. Winn, M., Isupov, M. & Murshudov, G. N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D 57, 122-133 (2001).